Published in Environ Sci Technol on September 11, 2012
Aggregate Exposure and Cumulative Risk Assessment-Integrating Occupational and Non-occupational Risk Factors. J Occup Environ Hyg (2015) 0.84
Use of the "Exposome" in the Practice of Epidemiology: A Primer on -Omic Technologies. Am J Epidemiol (2016) 0.76
Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev (2005) 5.51
Risk factors for hearing loss in US adults: data from the National Health and Nutrition Examination Survey, 1999 to 2002. Otol Neurotol (2009) 1.99
A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures. Toxicol Sci (2001) 1.71
Risk assessment of combined exposure to multiple chemicals: A WHO/IPCS framework. Regul Toxicol Pharmacol (2011) 1.67
IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit Rev Toxicol (2008) 1.61
If cumulative risk assessment is the answer, what is the question? Environ Health Perspect (2007) 1.46
IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol (2006) 1.44
Tools available to communities for conducting cumulative exposure and risk assessments. J Expo Sci Environ Epidemiol (2009) 1.33
Cumulative risk assessment for combined health effects from chemical and nonchemical stressors. Am J Public Health (2011) 1.21
The EPA's human exposure research program for assessing cumulative risk in communities. J Expo Sci Environ Epidemiol (2009) 1.16
Non-chemical stressors and cumulative risk assessment: an overview of current initiatives and potential air pollutant interactions. Int J Environ Res Public Health (2011) 1.07
Modeling joint exposures and health outcomes for cumulative risk assessment: the case of radon and smoking. Int J Environ Res Public Health (2011) 1.04
Conceptual models for cumulative risk assessment. Am J Public Health (2011) 1.03
Interaction of occupational and personal risk factors in workforce health and safety. Am J Public Health (2011) 0.99
Risk Assessment's New Era: part 2: Evolving Methods and Future Directions. Synergist (Akron) (2012) 0.98
Critical analysis of literature on low-dose synergy for use in screening chemical mixtures for risk assessment. Crit Rev Toxicol (2011) 0.96
Ethical and social issues in the use of biomarkers in epidemiological research. IARC Sci Publ (1997) 0.94
Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol (2008) 0.91
The Environmental Protection Agency's Community-Focused Exposure and Risk Screening Tool (C-FERST) and its potential use for environmental justice efforts. Am J Public Health (2011) 0.90
Novel methods for integrated risk assessment of cumulative stressors--results from the NoMiracle project. Sci Total Environ (2010) 0.86
The use of biomarkers in occupational health research, practice, and policy. Toxicol Lett (2011) 0.85
A weight of evidence approach for the assessment of the ototoxic potential of industrial chemicals. Toxicol Ind Health (2011) 0.83
An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion. Toxicol Sci (2002) 0.81
Incorporating nonchemical stressors into cumulative risk assessments. Toxicol Sci (2012) 0.80
Role of the aryl hydrocarbon receptor in cell cycle regulation. Toxicology (2002) 0.88
Resources for global risk assessment: the International Toxicity Estimates for Risk (ITER) and Risk Information Exchange (RiskIE) databases. Toxicol Appl Pharmacol (2008) 0.88
The evolution of skin notations for occupational risk assessment: a new NIOSH strategy. Regul Toxicol Pharmacol (2011) 0.87
In vitro human epidermal penetration of 1-bromopropane. J Toxicol Environ Health A (2011) 0.82
An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion. Toxicol Sci (2002) 0.81
Evaluation of asbestos exposure within the automotive repair industry: a study involving removal of asbestos-containing body sealants and drive clutch replacement. Regul Toxicol Pharmacol (2008) 0.81
Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern. Regul Toxicol Pharmacol (2011) 0.81
Efficacy of predictive modeling as a scientific criterion in dermal hazard identification for assignment of skin notations. Regul Toxicol Pharmacol (2011) 0.80
Evaluation of human relevance and mode of action for tunica vaginalis mesotheliomas resulting from oral exposure to acrylamide. Regul Toxicol Pharmacol (2008) 0.80
Carcinogen biomonitoring in human exposures and laboratory research: validation and application to human occupational exposures. Toxicol Lett (2002) 0.80
Scientific criteria used for the development of occupational exposure limits for metals and other mining-related chemicals. Regul Toxicol Pharmacol (2002) 0.79
Application of the threshold of toxicological concern concept to pharmaceutical manufacturing operations. Regul Toxicol Pharmacol (2005) 0.79
Assessment of airborne asbestos exposure during the servicing and handling of automobile asbestos-containing gaskets. Regul Toxicol Pharmacol (2006) 0.77
A Bayesian network model for biomarker-based dose response. Risk Anal (2010) 0.77
Derived Reference Doses (RfDs) for the environmental degradates of the herbicides alachlor and acetochlor: results of an independent expert panel deliberation. Regul Toxicol Pharmacol (2010) 0.77
Dose-response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: Results of a workshop. Crit Rev Toxicol (2013) 0.75
Recommendations for biomonitoring of emergency responders: focus on occupational health investigations and occupational health research. Mil Med (2013) 0.75
A look at state-level risk assessment in the United States: making decisions in the absence of federal risk values. Risk Anal (2012) 0.75
Peer consultation on relationship between PAC profile and toxicity of petroleum substances. Regul Toxicol Pharmacol (2012) 0.75